Gentamicin dosing in postpartum women with endometritis

American Journal of Obstetrics and Gynecology
G G BriggsM P Nageotte

Abstract

Postpartum women receiving gentamicin for endometritis were studied to determine if selective determination of gentamicin serum levels was cost-effective in terms of safety and efficacy. The women were randomized into two groups of 30 patients each. In the control group gentamicin serum levels were determined after the third dose. In the study group, levels were determined only if renal dysfunction was evident or if the patient failed to respond to therapy. Determination of serum levels did not assure a better therapeutic outcome in either group, as measured by hospital stay, duration of treatment, total cost of antibiotics, and hospital readmissions. Although pharmacokinetic dosing equations were used, the use of 1.75 mg/kg every 8 hours based on actual body weight in patients with average heights and weights would have produced acceptable results. We conclude that routine monitoring of gentamicin serum levels is not required in otherwise healthy postpartum women with endometritis.

Citations

Dec 18, 2004·Archives of Gynecology and Obstetrics·Stavros SifakisEugenios Koumantakis
Jun 1, 1996·Obstetrics and Gynecology·G Del PrioreM C Frederiksen
Aug 5, 2008·Clinical Obstetrics and Gynecology·Kristy Ward, Regan N Theiler
Apr 15, 2008·Emergency Medicine Clinics of North America·Diane L Gorgas
Mar 30, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Daniel MartinganoJeanne Carey
Mar 1, 2002·The Cochrane Database of Systematic Reviews·J AlexanderJ Sanghera
Apr 13, 2018·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Daniel MartinganoJeanne Carey
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Walter Chaim, Eliezer Burstein
Aug 1, 1995·Journal of Chemotherapy·P Periti
Apr 30, 2015·The Cochrane Database of Systematic Reviews·A Dhanya MackeenLinda Speer
Mar 1, 1997·Infectious Disease Clinics of North America·P Duff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.